Ｇ−モダリス (TSE) · Health Technology. stock live price and technical analysis view. Follow TSE data on Alerta Chart.
Checking data access...
Modalis Therapeutics Corp. engages in the development of gene therapy drugs. It uses CRISPR-GNDM, a gene modulation technology that assists patients fighting with genetic disorders. The company was founded by Haruhiko Morita and Osamu Nureki in January 2016 and is headquartered in Tokyo, Japan.
With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.
Start for Free